NeRRe Therapeutics Ltd.

ACTIVE

United Kingdomwww.nerretherapeutics.comHolding11–50 employeesEstablished: 2012-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2012

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

60.0%

Phase 1

40.0%

Trial Status Distribution

Completed

80.0%

Withdrawn

20.0%

Clinical Trials

Trials sponsored by this organization (5)

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

Phase 2

Completed

interventional

Aug 202280 participants

Mass Balance Study of [14C]-Orvepitant Oral Solution in Healthy Male Subjects

Phase 1

Completed

interventional

Jun 20206 participants

A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy Volunteers

Phase 1

Completed

interventional

Jun 201816 participants

A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis

A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough

Phase 2

Completed

interventional

May 2017315 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations